Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00522145
Status:
COMPLETED
Last Update Posted:
2022-05-13
First Post:
2007-08-27
Brief Title:
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib
Sponsor:
Organization:
Kadmon Corporation LLC